223 related articles for article (PubMed ID: 28365779)
1. Personalized genome sequencing coupled with iPSC technology identifies GTDC1 as a gene involved in neurodevelopmental disorders.
Aksoy I; Utami KH; Winata CL; Hillmer AM; Rouam SL; Briault S; Davila S; Stanton LW; Cacheux V
Hum Mol Genet; 2017 Jan; 26(2):367-382. PubMed ID: 28365779
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of Neurite Outgrowth and Cell Migration in Autism and Other Neurodevelopmental Disorders.
Prem S; Millonig JH; DiCicco-Bloom E
Adv Neurobiol; 2020; 25():109-153. PubMed ID: 32578146
[TBL] [Abstract][Full Text] [Related]
3. Induced pluripotent stem cells as a tool to study brain circuits in autism-related disorders.
Vitrac A; Cloëz-Tayarani I
Stem Cell Res Ther; 2018 Aug; 9(1):226. PubMed ID: 30139379
[TBL] [Abstract][Full Text] [Related]
4. Understanding the molecular basis of autism in a dish using hiPSCs-derived neurons from ASD patients.
Lim CS; Yang JE; Lee YK; Lee K; Lee JA; Kaang BK
Mol Brain; 2015 Sep; 8(1):57. PubMed ID: 26419846
[TBL] [Abstract][Full Text] [Related]
5. Complement C4 Is Reduced in iPSC-Derived Astrocytes of Autism Spectrum Disorder Subjects.
Mansur F; Teles E Silva AL; Gomes AKS; Magdalon J; de Souza JS; Griesi-Oliveira K; Passos-Bueno MR; Sertié AL
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299197
[TBL] [Abstract][Full Text] [Related]
6. Modelling Autistic Neurons with Induced Pluripotent Stem Cells.
Kathuria A; Sala C; Verpelli C; Price J
Adv Anat Embryol Cell Biol; 2017; 224():49-64. PubMed ID: 28551750
[TBL] [Abstract][Full Text] [Related]
7. Stem cell-derived neurons from autistic individuals with SHANK3 mutation show morphogenetic abnormalities during early development.
Kathuria A; Nowosiad P; Jagasia R; Aigner S; Taylor RD; Andreae LC; Gatford NJF; Lucchesi W; Srivastava DP; Price J
Mol Psychiatry; 2018 Mar; 23(3):735-746. PubMed ID: 28948968
[TBL] [Abstract][Full Text] [Related]
8. Modeling the autistic cell: iPSCs recapitulate developmental principles of syndromic and nonsyndromic ASD.
Ben-Reuven L; Reiner O
Dev Growth Differ; 2016 Jun; 58(5):481-91. PubMed ID: 27111774
[TBL] [Abstract][Full Text] [Related]
9. Gene Regulation Analysis Reveals Perturbations of Autism Spectrum Disorder during Neural System Development.
Li D; Xu J; Yang MQ
Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946850
[TBL] [Abstract][Full Text] [Related]
10. The Use of Induced Pluripotent Stem Cell Technology to Advance Autism Research and Treatment.
Acab A; Muotri AR
Neurotherapeutics; 2015 Jul; 12(3):534-45. PubMed ID: 25851569
[TBL] [Abstract][Full Text] [Related]
11. The Autism Spectrum Disorders Stem Cell Resource at Children's Hospital of Orange County: Implications for Disease Modeling and Drug Discovery.
Brick DJ; Nethercott HE; Montesano S; Banuelos MG; Stover AE; Schutte SS; O'Dowd DK; Hagerman RJ; Ono M; Hessl DR; Tassone F; Schwartz PH
Stem Cells Transl Med; 2014 Nov; 3(11):1275-86. PubMed ID: 25273538
[TBL] [Abstract][Full Text] [Related]
12. Human iPSC-based models highlight defective glial and neuronal differentiation from neural progenitor cells in metachromatic leukodystrophy.
Frati G; Luciani M; Meneghini V; De Cicco S; Ståhlman M; Blomqvist M; Grossi S; Filocamo M; Morena F; Menegon A; Martino S; Gritti A
Cell Death Dis; 2018 Jun; 9(6):698. PubMed ID: 29899471
[TBL] [Abstract][Full Text] [Related]
13. A novel human model of the neurodegenerative disease GM1 gangliosidosis using induced pluripotent stem cells demonstrates inflammasome activation.
Son MY; Kwak JE; Seol B; Lee DY; Jeon H; Cho YS
J Pathol; 2015 Sep; 237(1):98-110. PubMed ID: 25925601
[TBL] [Abstract][Full Text] [Related]
14. Establishment of an induced pluripotent stem cell (iPSC) line from a 9-year old male with autism spectrum disorder (ASD).
Varga E; Nemes C; Bock I; Táncos Z; Berzsenyi S; Lévay G; Román V; Kobolák J; Dinnyés A
Stem Cell Res; 2017 May; 21():19-22. PubMed ID: 28677532
[TBL] [Abstract][Full Text] [Related]
15. A chimeric mouse model to study human iPSC-derived neurons: the case of a truncating SHANK3 mutation.
Vitrac A; Pons S; Balkota M; Lemière N; Raïs C; Bourgeois JP; Maskos U; Bourgeron T; Cloëz-Tayarani I
Sci Rep; 2020 Aug; 10(1):13315. PubMed ID: 32769989
[TBL] [Abstract][Full Text] [Related]
16. High-throughput screening identifies histone deacetylase inhibitors that modulate GTF2I expression in 7q11.23 microduplication autism spectrum disorder patient-derived cortical neurons.
Cavallo F; Troglio F; Fagà G; Fancelli D; Shyti R; Trattaro S; Zanella M; D'Agostino G; Hughes JM; Cera MR; Pasi M; Gabriele M; Lazzarin M; Mihailovich M; Kooy F; Rosa A; Mercurio C; Varasi M; Testa G
Mol Autism; 2020 Nov; 11(1):88. PubMed ID: 33208191
[TBL] [Abstract][Full Text] [Related]
17. Cellular and molecular characterization of multiplex autism in human induced pluripotent stem cell-derived neurons.
Lewis EMA; Meganathan K; Baldridge D; Gontarz P; Zhang B; Bonni A; Constantino JN; Kroll KL
Mol Autism; 2019; 10():51. PubMed ID: 31893020
[TBL] [Abstract][Full Text] [Related]
18. Idiopathic Autism: Cellular and Molecular Phenotypes in Pluripotent Stem Cell-Derived Neurons.
Liu X; Campanac E; Cheung HH; Ziats MN; Canterel-Thouennon L; Raygada M; Baxendale V; Pang AL; Yang L; Swedo S; Thurm A; Lee TL; Fung KP; Chan WY; Hoffman DA; Rennert OM
Mol Neurobiol; 2017 Aug; 54(6):4507-4523. PubMed ID: 27356918
[TBL] [Abstract][Full Text] [Related]
19. In vitro characterization of neurite extension using induced pluripotent stem cells derived from lissencephaly patients with TUBA1A missense mutations.
Bamba Y; Shofuda T; Kato M; Pooh RK; Tateishi Y; Takanashi J; Utsunomiya H; Sumida M; Kanematsu D; Suemizu H; Higuchi Y; Akamatsu W; Gallagher D; Miller FD; Yamasaki M; Kanemura Y; Okano H
Mol Brain; 2016 Jul; 9(1):70. PubMed ID: 27431206
[TBL] [Abstract][Full Text] [Related]
20. Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models.
Haggarty SJ; Silva MC; Cross A; Brandon NJ; Perlis RH
Mol Cell Neurosci; 2016 Jun; 73():104-15. PubMed ID: 26826498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
